YM BioSciences
Quick facts
Phase 2 pipeline
- AeroLEF · Respiratory
AeroLEF is a liposome-encapsulated formulation of budesonide, a corticosteroid that reduces inflammation.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: